Lumida
/EOLS
⌘K
Evolus Inc

Evolus Inc

EOLS
$7.84USD-0.88%-0.07 today

MARKET CAP

517.8M

P/E (TTM)

FWD P/E

DAY RANGE

$8 – $8

52W RANGE

$4
$9

AI Summary

Stalk
Buy NowMedium

EOLS remains in a Stage 2 advance with higher highs and higher lows intact. A recent pullback into the rising 9/20 EMAs has held on healthy volume, indicating potential absorption and continuation. Bearish Exhaustion at the recent high signals seller fatigue and increases the probability of a bottoming bounce. Medium-term bias remains bullish, and short-term conditions favor execution now at support near the EMAs.

  • Q2 2026 revenue rose 21% YoY to $84.1M, beating EPS by 156.8%
  • Adjusted EBITDA reached $4.7M for the third straight quarter
  • Negative earnings yield and low book-to-price ratio indicate stretched valuation
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$99.7M$148.6M$202.1M$266.3M$297.2M
YoY %+76.3%+49.1%+36.0%+31.8%+11.6%
P / Sales3.3x3.0x2.8x2.6x1.4x
EV / Sales3.5x3.7x3.5x3.1x2.1x
Gross Profit, Adj.$56.1M$89.8M$137.6M$182.3M$197.1M
YoY %+46.8%+59.9%+53.2%+32.5%+8.1%
Margin %56.3%60.4%68.1%68.5%66.3%
EV / Gross Profit6.3x6.1x5.2x4.5x3.2x
EBITDA, Adj.$-57.3M$-55.9M$-44.1M$-29.1M$-23.7M
YoY %+6.1%+2.5%+21.0%+34.0%+18.6%
Margin %-57.5%-37.6%-21.8%-10.9%-8.0%
EV / EBITDA-6.2x-9.7x-16.2x-28.3x-26.3x
EBIT$-38.1M$-65.3M$-49.2M$-34.4M$-32.7M
YoY %+75.4%-71.4%+24.6%+30.1%+5.1%
Margin %-38.2%-44.0%-24.4%-12.9%-11.0%
EV / EBIT-9.3x-8.3x-14.5x-24.0x-19.1x
Net Income$-46.8M$-74.4M$-61.7M$-50.4M$-51.6M
YoY %+71.3%-59.0%+17.1%+18.3%-2.4%
Net Margin-47.0%-50.1%-30.5%-18.9%-17.4%
EPS (GAAP)-$0.94-$1.33-$1.08-$0.81-$0.80
YoY %+80.5%-41.5%+18.8%+25.0%+1.2%